Key facts
- This page summarizes Margaret Dalesandro's Form 4 filing for ONCOSEC MEDICAL Inc.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 Aug 2021, 17:31.
Margaret Dalesandro - 23 Aug 2021 Form 4 Insider Report for ONCOSEC MEDICAL Inc
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 23 Aug 2021
- Net transaction value
- +$37,800
- SEC form
- 4
- Accepted by SEC
- 25 Aug 2021, 17:31:11 UTC
- Prior SEC filing
- 29 Jun 2021
- Next SEC filing
- 02 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Margaret Dalesandro
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Margaret Dalesandro filed Form 4 for ONCOSEC MEDICAL Inc on 25 Aug 2021.
Change
- Previous filing in this sequence was filed on 29 Jun 2021.
- Current net transaction value: +$37,800.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ONCS
transaction
Common Stock
Purchase
- Transaction value
- $37,800
- Shares
- +20,000
- Change %
- Price
- $1.89*
- Shares after
- 20,000
- Date
- 23 Aug 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.